Short answer · Medically reviewed summary · Last updated: 2026-04-07
Pulmonary Hypertension is a complex condition characterized by high blood pressure in the arteries of the lungs, which can be caused by underlying heart or lung diseases, chronic blood clots, genetic mutations, or specific environmental exposures. While the exact trigger remains unknown in cases of Idiopathic Pulmonary Arterial Hypertension, medical research is actively mapping how these factors cause the blood vessels in the lungs to narrow and thicken over time. What causes Pulmonary Hypertension? The causes of Pulmonary Hypertension are classified into five distinct groups by the World Health Organization (WHO), depending on the underlying mechanism.
Pulmonary Hypertension is a complex condition characterized by high blood pressure in the arteries of the lungs, which can be caused by underlying heart or lung diseases, chronic blood clots, genetic mutations, or specific environmental exposures. While the exact trigger remains unknown in cases of Idiopathic Pulmonary Arterial Hypertension, medical research is actively mapping how these factors cause the blood vessels in the lungs to narrow and thicken over time.
The causes of Pulmonary Hypertension are classified into five distinct groups by the World Health Organization (WHO), depending on the underlying mechanism. The most common cause is left-sided heart disease or chronic lung disease (such as COPD or interstitial lung disease). In other cases, Pulmonary Hypertension develops due to chronic blood clots (Chronic Thromboembolic Pulmonary Hypertension) or as a primary disease of the lung arteries known as Pulmonary Arterial Hypertension (PAH). Think of your lung arteries like a garden hose; if the hose becomes stiff or narrowed, the heart must pump significantly harder to force blood through, leading to the high pressure we identify as Pulmonary Hypertension.
Genetic factors play a significant role in certain forms of the disease. Heritable Pulmonary Arterial Hypertension is often linked to mutations in specific genes, most notably the BMPR2 gene. It is important to note that carrying a genetic mutation does not guarantee that a person will develop the condition; rather, it increases the susceptibility. Geneticists estimate that roughly 15-20% of patients with idiopathic PAH have a family history or a detectable genetic mutation. Other genes, such as ALK1, ENG, and SMAD9, are also currently under investigation for their role in the development of Pulmonary Hypertension.
Distinguishing between a cause and a risk factor is vital for patient understanding. A cause is a direct trigger, while a risk factor increases the likelihood of developing the condition. Known risk factors and potential triggers for Pulmonary Hypertension include:
While we have identified many pathways that contribute to Pulmonary Hypertension, the etiology is not fully understood for every patient. Current research is focused on the "multiple-hit" hypothesis, which suggests that a genetic predisposition combined with an environmental "second hit" (such as a viral infection or metabolic shift) is required to trigger the disease process. Researchers are utilizing advanced genetic sequencing and cellular models to understand why some individuals with identical risk profiles develop the condition while others do not. The 101 members of the DiseaseMaps.org community contribute to this body of knowledge by sharing their lived experiences, which helps researchers identify patterns in symptom onset and disease progression.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of a qualified healthcare provider with any questions regarding a medical condition.